Phase 4 Fluticasone Furoate Nasal Spray (VERAMYST) Long Term Pediatric Growth Study.

PHASE4CompletedINTERVENTIONAL
Enrollment

474

Participants

Timeline

Start Date

November 26, 2007

Primary Completion Date

March 1, 2011

Study Completion Date

March 17, 2011

Conditions
Rhinitis, Allergic, Perennial
Interventions
DRUG

Fluticasone furoate nasal spray

Fluticasone furoate nasal spray 110mg QD

DRUG

Placebo nasal spray

Placebo nasal spray

Trial Locations (74)

1425

GSK Investigational Site, Buenos Aires

2000

GSK Investigational Site, Rosario

3000

GSK Investigational Site, Santa Fe

15212

GSK Investigational Site, Pittsburgh

15241

GSK Investigational Site, Pittsburgh

16801

GSK Investigational Site, Altoona

19013

GSK Investigational Site, Upland

20122

GSK Investigational Site, Milan

20129

GSK Investigational Site, Milan

21236

GSK Investigational Site, Baltimore

23219

GSK Investigational Site, Richmond

23229

GSK Investigational Site, Richmond

29118

GSK Investigational Site, Orangeburg

29303

GSK Investigational Site, Spartanburg

29414

GSK Investigational Site, Charleston

30045

GSK Investigational Site, Lawrenceville

30281

GSK Investigational Site, Stockbridge

30501

GSK Investigational Site, Gainesville

33134

GSK Investigational Site, Coral Gables

33613

GSK Investigational Site, Tampa

34295

GSK Investigational Site, Montpellier

34471

GSK Investigational Site, Ocala

36203

GSK Investigational Site, Oxford

43560

GSK Investigational Site, Sylvania

44718

GSK Investigational Site, Canton

46208

GSK Investigational Site, Indianapolis

47713

GSK Investigational Site, Evansville

48197

GSK Investigational Site, Ypsilanti

55441

GSK Investigational Site, Plymouth

64093

GSK Investigational Site, Warrensburg

65401

GSK Investigational Site, Rolla

66215

GSK Investigational Site, Lenexa

68131

GSK Investigational Site, Omaha

70006

GSK Investigational Site, Metairie

72205

GSK Investigational Site, Little Rock

73112

GSK Investigational Site, Oklahoma City

73120

GSK Investigational Site, Oklahoma City

75230

GSK Investigational Site, Dallas

75246

GSK Investigational Site, Dallas

76083

GSK Investigational Site, Le Havre

76712

GSK Investigational Site, Waco

77054

GSK Investigational Site, Houston

78028

GSK Investigational Site, Kerrville

78205

GSK Investigational Site, San Antonio

78229

GSK Investigational Site, San Antonio

79903

GSK Investigational Site, El Paso

79925

GSK Investigational Site, El Paso

90274

GSK Investigational Site, Rolling Hills Estates

90806

GSK Investigational Site, Long Beach

90808

GSK Investigational Site, Long Beach

92083

GSK Investigational Site, Vista

92506

GSK Investigational Site, Riverside

92647

GSK Investigational Site, Huntington Beach

97213

GSK Investigational Site, Portland

97504

GSK Investigational Site, Medford

68123-4303

GSK Investigational Site, Bellevue

05403

GSK Investigational Site, South Burlington

B6500BWQ

GSK Investigational Site, Nueve de Julio

S2000DBS

GSK Investigational Site, Rosario

C1121ABE

GSK Investigational Site, Buenos Aires

C1425BEN

GSK Investigational Site, Buenos Aires

M5500CCG

GSK Investigational Site, Mendoza

R2M 5L9

GSK Investigational Site, Winnipeg

L6T 3T1

GSK Investigational Site, Brampton

L5A 3V4

GSK Investigational Site, Mississauga

M4V 1R2

GSK Investigational Site, Toronto

C1A 8T5

GSK Investigational Site, Charlottetown

G1V 4M6

GSK Investigational Site, Québec

G8T 7A1

GSK Investigational Site, Trois-Rivières

Unknown

GSK Investigational Site, Viña del Mar

GSK Investigational Site, Santiago

02000

GSK Investigational Site, Laon

06156

GSK Investigational Site, Perugia

Lima 27

GSK Investigational Site, Lima

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY